These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33582546)

  • 1. Establishment of a TLR3 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Han HJ; Kim JH
    Stem Cell Res; 2021 Apr; 52():102187. PubMed ID: 33582546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a KSCBi005-A-5(TLR8KO-A10) homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Han HJ; Han HW; Seo HH; Kim JH
    Stem Cell Res; 2019 Oct; 40():101561. PubMed ID: 31526944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Han HJ; Seo HH; Han HW; Kim JH
    Stem Cell Res; 2019 Oct; 40():101520. PubMed ID: 31445394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a TLR2 knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Han HJ; Kim JH
    Stem Cell Res; 2021 Dec; 57():102578. PubMed ID: 34710836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR3 and MDA5 Knockout DF-1 cells Enhance Replication of Avian Orthoavulavirus 1.
    Lee CW; Kc M; Ngunjiri JM; Ghorbani A; Lee K
    Avian Dis; 2023 Mar; 67(1):94-101. PubMed ID: 37140117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
    Yumlu S; Bashir S; Stumm J; Kühn R
    Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KSCBi005-A-8(hiPSC-PD-L1KO), a PD-L1 knockout human induced pluripotent stem cell line for demonstrating the role of the PD-1/PD-L1 axis.
    Han HJ; Kim JH
    Stem Cell Res; 2023 Oct; 72():103196. PubMed ID: 37690432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KSCBi005-A-10(hiPSC-HIF1αKO), a HIF1α knockout human induced pluripotent stem cell line, for demonstrating the role of cellular response to hypoxia.
    Han HJ; Kim JH
    Stem Cell Res; 2024 Jun; 77():103415. PubMed ID: 38636267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 Genome Editing of Human-Induced Pluripotent Stem Cells Followed by Granulocytic Differentiation.
    Dannenmann B; Nasri M; Welte K; Skokowa J
    Methods Mol Biol; 2020; 2115():471-483. PubMed ID: 32006418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.
    Giacalone JC; Sharma TP; Burnight ER; Fingert JF; Mullins RF; Stone EM; Tucker BA
    Curr Protoc Stem Cell Biol; 2018 Feb; 44():5B.7.1-5B.7.22. PubMed ID: 29512106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative Contributions of the cGAS-STING and TLR3 Signaling Pathways to Attenuation of Herpes Simplex Virus 1 Replication.
    Latif MB; Raja R; Kessler PM; Sen GC
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31896590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avian Toll-like receptor 3 isoforms and evaluation of Toll-like receptor 3-mediated immune responses using knockout quail fibroblast cells.
    Kc M; Ngunjiri JM; Lee J; Ahn J; Elaish M; Ghorbani A; Abundo MEC; Lee K; Lee CW
    Poult Sci; 2020 Dec; 99(12):6513-6524. PubMed ID: 33248566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon β (IFN-β) Production during the Double-stranded RNA (dsRNA) Response in Hepatocytes Involves Coordinated and Feedforward Signaling through Toll-like Receptor 3 (TLR3), RNA-dependent Protein Kinase (PKR), Inducible Nitric Oxide Synthase (iNOS), and Src Protein.
    Zhang L; Xiang W; Wang G; Yan Z; Zhu Z; Guo Z; Sengupta R; Chen AF; Loughran PA; Lu B; Wang Q; Billiar TR
    J Biol Chem; 2016 Jul; 291(29):15093-107. PubMed ID: 27226571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a homozygous ZBTB7A knockout human induced pluripotent stem line by CRISPR/Cas9 editing.
    Chen D; Song B; Cheng Y; Zhu L; Lu D; Liu N; Yang Y; Sun X
    Stem Cell Res; 2021 Aug; 55():102494. PubMed ID: 34403853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an NANS homozygous knockout human induced pluripotent stem cell line by the insertion of GFP-P2A-Puro via CRISPR/Cas9 editing.
    Bu Q; Zhang H; Liu Q; Dai Y; Wei Q; Xue A; Huang Y; Zhong K; Huang Y; Gao H; Cen X
    Stem Cell Res; 2020 Dec; 49():102052. PubMed ID: 33130469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a TLR2 homozygous knockout human embryonic stem cell line WAe001-A-64 using CRISPR/Cas9 editing.
    Getachew A; Yang Z; Huang X; Wu F; Liu YY; Yan C; Yang F; Li Y
    Stem Cell Res; 2021 Jul; 54():102401. PubMed ID: 34058685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of human induced pluripotent stem cell line carrying SCN5AC2204>T Brugada mutation (MUSli009-A-1) introduced by CRISPR/Cas9-mediated genome editing.
    Angsutararux P; Luanpitpong S; Chingsuwanrote P; Supraditaporn K; Waeteekul S; Terbto P; Lorthongpanich C; Laowtammathron C; U-Pratya Y; Issaragrisil S
    Stem Cell Res; 2019 Dec; 41():101618. PubMed ID: 31677524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 3 (TLR3) and the development of type 1 diabetes mellitus.
    Assmann TS; Brondani Lde A; Bouças AP; Canani LH; Crispim D
    Arch Endocrinol Metab; 2015 Feb; 59(1):4-12. PubMed ID: 25926108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of two LRRK2 homozygous knockout human induced pluripotent stem cell lines using CRISPR/Cas9.
    Chen S; Luo Z; Ward C; Ibañez DP; Liu H; Zhong X; Sharma NK; Qin B; Fan W; Wang D
    Stem Cell Res; 2020 May; 45():101804. PubMed ID: 32339904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of induced pluripotent stem cell line (TMOi001-A-11) carrying a homozygous deletion in the synemin gene using CRISPR/Cas9.
    Gargano C; Vartanian-Grimaldi JS; Hovhannisyan Y; Joanne P; Agbulut O; Li Z; Parlakian A; Decaux JF
    Stem Cell Res; 2023 Dec; 73():103254. PubMed ID: 38035530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.